PAYER READY CREDENTIALING & COMPLIANCE
ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 D59.31

Billable / Specific HCC v28: 46 MCC

Infection-associated hemolytic-uremic syndrome

D59
Block
2
Synonyms
540
LCDs
6
Payer Policies
3
Linked CPTs

About ICD-10-CM D59.31

ICD-10-CM code D59.31 represents Infection-associated hemolytic-uremic syndrome. This is a billable/specific code in the Blood and Blood-forming Organs chapter (block D59). The 2026 edition of ICD-10-CM D59.31 became effective on October 1, 2025.

Coding Tips for D59.31

Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.

HCC capture: document with MEAT each year

D59.31 is a CMS-HCC v28 risk-adjustment code (category 46). To count for the patient Risk Adjustment Factor (RAF), document the diagnosis with MEAT language each calendar year: Monitored, Evaluated, Assessed, Treated. A diagnosis on the problem list alone does not satisfy CMS RADV audit standards. Include the diagnosis in the assessment with current status and current treatment plan.

Inpatient DRG impact: MCC

D59.31 is designated MCC for MS-DRG grouping. On inpatient claims, this code can shift the DRG to the with-MCC variant when documented as a present-on-admission secondary diagnosis. Hospital CDI programs flag MCC opportunities during chart review. Failure to capture this code may leave 30 to 80 percent of the inpatient stay revenue unrealized.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under D59.31. Per CMS ICD-10-CM Tabular 2026.

  • Shiga toxin-producing E. coli [STEC] related hemolytic uremic syndrome
  • Typical hemolytic uremic syndrome

Use Additional Code

When coding D59.31, also report these additional codes when applicable.

  • code to identify associated infection, such as :
  • E. coli infection (B96.2-)
  • Human immunodeficiency virus [HIV] disease (B20)
  • Pneumococcal meningitis (G00.1)
  • Pneumococcal pneumonia (J13)
  • Sepsis due to Streptococcus pneumoniae (A40.3)
  • Shigella dysenteriae (A03.9)
  • Streptococcus pneumoniae as the cause of diseases classified elsewhere (B95.3)

Medicare Advantage HCC Impact

CMS-HCC v28 (current)
Category 46
ESRD-HCC
Category 46
RxHCC (Part D)
Category 46

Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.

Inpatient DRG Impact, MCC

codes Infection-associated hemolytic-uremic syndrome. As a Major Complication/Comorbidity (MCC), this can shift the DRG assignment to a higher-weighted category, substantial reimbursement impact.

Medicare LCD Coverage for D59.31

Local Coverage Determinations (LCDs) from CMS MACs that list D59.31 as a covered diagnosis.

540 LCDs

Showing top 10 of 540 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb
Article ID: 54548, Effective: 2025-10-01 00:00:00, 18 covered, 0 non-covered
CPT Q5152 →
CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb
Article ID: 54548, Effective: 2025-10-01 00:00:00, 18 covered, 0 non-covered
CPT J1299 →
CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb
Article ID: 54548, Effective: 2025-10-01 00:00:00, 18 covered, 0 non-covered
CPT Q5151 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87555 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87653 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87486 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87626 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 0109U →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87516 →
CMS LCD: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Article ID: 58761, Effective: 2026-03-12 00:00:00, 851 covered, 0 non-covered
CPT 87517 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing D59.31.

6 policies

5 Medicare

Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb
Policy ID: ART-54548
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Policy ID: ART-58710
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Policy ID: ART-58720
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Policy ID: ART-58747
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Policy ID: ART-58761

1 Aetna

Extracorporeal Immunoadsorption (Prosorba Column)
Policy ID: CPB-0355

CPT Codes Commonly Billed with D59.31

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

3 linkages
  • Q5152 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD
  • Q5151 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD
  • J1299 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD

ICD-10 D59.31, Billing FAQ

Is ICD-10 code D59.31 billable? +

Yes, D59.31 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to D59.31? +

ICD-10 D59.31 includes: Shiga toxin-producing E. coli [STEC] related hemolytic uremic syndrome; Typical hemolytic uremic syndrome.

Does D59.31 affect Medicare Advantage HCC risk adjustment? +

Yes. D59.31 maps to CMS-HCC v28 category 46. Capture this diagnosis annually for accurate Medicare Advantage risk score.

Is D59.31 a CC or MCC for inpatient DRG? +

Yes, this code is designated as MCC. Documenting as a secondary diagnosis on inpatient claims can shift the DRG to a higher-weighted category.

What CPT codes are commonly billed with D59.31? +

Procedures frequently paired with D59.31 include: Q5152, Q5151, J1299.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on July 17, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Every month un-credentialed is revenue you never bill

Sign up free, add your first provider, and watch the pipeline start moving this week.

Ask CredBrain

Answers from your credentialing team's verified knowledge base

Hi, I'm CredBrain. I answer from your credentialing team's verified knowledge base: payer join paths, state rules, timelines, associate billing, and enrollment workflows. If I don't have a verified answer, I'll say so and point you to your team. What would you like to know?

Try asking